Notably, ANKRD22 also counteracted the reduction in lipid content in NPC cells mediated by METTL14 knockdown, indicating that METTL14 upregulates ANKRD22 expression to promote lipid metabolism in NPC cells. The gene discussed is METTL14; the disease is nasopharyngeal carcinoma.